Related Experiment Videos
Human parainfluenza virus induces a type-specific protective immune response
R Ray1, Y Matsuoka, T L Burnett
1Molecular Engineering Associates, Birmingham, Alabama 35205.
The Journal of Infectious Diseases
|September 1, 1990
Summary
Intranasal immunization with parainfluenza virus type 2 glycoproteins induced type-specific immunity in hamsters. This vaccine approach did not provide cross-protection against other parainfluenza virus types, suggesting a need for multivalent vaccines.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- Human parainfluenza viruses (HPIVs) are significant respiratory pathogens.
- Developing effective vaccines against HPIVs remains a challenge due to limited cross-protection.
Purpose of the Study:
- To investigate the induction of type-specific and cross-protective immune responses against HPIVs.
- To evaluate the immunogenicity and protective efficacy of envelope glycoproteins from parainfluenza virus type 2 (HPIV-2).
Main Methods:
- Solubilization of HPIV-2 envelope glycoproteins (HN and F0) using octylglucoside.
- Intranasal immunization of hamsters with detergent-soluble HPIV-2 glycoproteins.
- Challenge infection with live HPIV-1, HPIV-2, and HPIV-3.
Main Results:
- Intranasal immunization with HPIV-2 glycoproteins conferred complete protection against HPIV-2 challenge.
- No significant protection was observed against challenge with HPIV-1 or HPIV-3.
- Type-specific neutralizing antibodies were detected in sera and bronchial lavages of immunized animals.
Conclusions:
- HPIV-2 envelope glycoproteins induce a type-specific immune response.
- A single-type HPIV vaccine may not be sufficient for broad protection.
- A multivalent parainfluenza virus vaccine is likely necessary for effective protection against natural infections.